Puertollano R, Alonso M A
Centro de Biología Molecular "Severo Ochoa," Universidad Autónoma de Madrid, Consejo Superior de Investigaciones Científicas, Cantoblanco, 28049-Madrid, Spain.
J Biol Chem. 1998 May 22;273(21):12740-5. doi: 10.1074/jbc.273.21.12740.
The MAL (VIP17, MVP17) proteolipid, an integral membrane protein with specific residence in glycolipid-enriched membrane (GEM) microdomains, has been recently proposed as a component of the protein machinery for GEM vesiculation. In this work, we have searched the COOH terminus of MAL for sorting determinants responsible for targeting to GEMs. This has allowed the identification of the sequence Leu-Ile-Arg-Trp (LIRW) as necessary for the access of MAL to GEMs. This motif requires at least one additional amino acid at its COOH end for full effectiveness. The arginine within the LIRW motif is the most crucial residue for targeting to GEMs, tryptophan replacement affects targeting to a lesser extent, and the leucine-isoleucine pair tolerates substitution by valine, but not by alanine, without effect on targeting. Pulse-chase experiments indicate that the LIRW tetrapeptide is required for access to GEMs early after MAL biosynthesis. Interestingly, the loss of the capacity of the MAL protein to be incorporated into GEMs correlated with the loss of its response to brefeldin A treatment. This is the first identification of a juxtamembrane peptide motif required for incorporation of an integral membrane protein into GEMs.
MAL(VIP17、MVP17)蛋白脂质是一种整合膜蛋白,特异性定位于富含糖脂的膜(GEM)微结构域,最近被认为是GEM囊泡形成蛋白机制的一个组成部分。在这项研究中,我们在MAL的COOH末端寻找负责靶向GEM的分选决定因素。这使得我们鉴定出Leu-Ile-Arg-Trp(LIRW)序列是MAL进入GEM所必需的。该基序在其COOH末端至少需要一个额外的氨基酸才能发挥完全作用。LIRW基序中的精氨酸是靶向GEM最关键的残基,色氨酸替代对靶向的影响较小,亮氨酸-异亮氨酸对可被缬氨酸替代,但不能被丙氨酸替代,且不影响靶向。脉冲追踪实验表明,MAL生物合成后早期进入GEM需要LIRW四肽。有趣的是,MAL蛋白整合到GEM中的能力丧失与其对布雷菲德菌素A处理的反应丧失相关。这是首次鉴定出整合膜蛋白整合到GEM中所需的近膜肽基序。